Posted by Michael Wonder on 21 Nov 2025
Merck Canada and the pan-Canadian Pharmaceutical Alliance successfully complete negotiations for Winrevair (sotatercept)
20 November 2025 - Merck announced that it has successfully completed negotiations with the pan‑Canadian Pharmaceutical Alliance (pCPA) for Winrevair (sotatercept).
The pCPA negotiates on behalf of the provinces, territories, and federal drug programs serving as a critical step in bringing Winrevair closer to public reimbursement.
